Highlights
- Reliance industries have developed vaccine
- Clinical trials to be conducted in 10 different locations across India
The Subject Expert Committee (SEC) has recommended the clinical trails for the Phase-1 of the vaccine. The SEC has two doses, which ae 8 days apart. To gain approval from the Drugs Controller General India (DCGI), the Reliance Life Sciences group must carry ....
Tags : Clinical trial, vaccine, phase-1, Reliance, indigenous,
comments (0)